Back to Search
STEPHEN GORE, M.D.
M.D.
Emergency Medicine Physician
NPI: 1639445406IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
036.136626(IL)
Education
OTHER
Class of 2012
Research & Publications (20)
Inhibitors of signaling in myelodysplastic syndrome.
PMID 15494298·Best Pract Res Clin Haematol·2004
6-review
Trends in health sciences library and information science research: an analysis of research publications in the Bulletin of the Medical Library Association and Journal of the Medical Library Association from 1991 to 2007.
PMID 19626146·J Med Libr Assoc·2009
8-other
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.
PMID 19546476·Blood·2009
3-trial
Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs.
PMID 19647903·Eur J Med Chem·2009
7-preclinical
Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
PMID 19464085·Eur J Med Chem·2009
8-other
Neuronal differentiation in basal cell carcinoma: possible relationship to Hedgehog pathway activation?
PMID 19479712·J Pathol·2009
8-other
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.
PMID 19652201·Blood·2009
3-trial
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
PMID 19167676·Biol Blood Marrow Transplant·2009
6-review
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.
PMID 19109557·Blood·2009
3-trial
Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
PMID 19036593·Bioorg Med Chem·2009
7-preclinical
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
PMID 19230772·Lancet Oncol·2009
3-trial
DNA methyltransferase inhibitors: class effect or unique agents?
PMID 18398728·Leuk Lymphoma·2008
4-observational
Comparative modelling by restraint-based conformational sampling.
PMID 18237407·BMC Struct Biol·2008
4-observational
Future directions in myelodysplastic syndrome: newer agents and the role of combination approaches.
PMID 18813208·Cancer Control·2008
6-review
Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics.
PMID 18593891·Cancer Res·2008
8-other
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.
PMID 18483374·Clin Cancer Res·2008
3-trial
New agents for the treatment of AML recent study findings.
PMID 19205109·Clin Adv Hematol Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1750 W HARRISON ST STE 108
CHICAGO, IL 60612 - Phone
- (312) 942-5110
Quick Facts
- NPI
- 1639445406
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile